A
Name | Dosage form | ATC code |
---|---|---|
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 50 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 20 ml № 1 | A11HA03 |
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 100 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 20 ml № 1 | A11HA03 |
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 300 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
300 mg/ml, 20 ml № 1 | A11HA03 |
Aquavit-D3 Aquavit-D3 375 mcg/ml, 10 ml № 1 Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
375 mcg/ml, 10 ml № 1 | A11CC05 |
Ascorbic acid Ascorbic acid 50 mg № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg № 50 | A11GA01 |
Ascorbic acid Ascorbic acid 50 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 2 ml № 10, № 100 | A11GA01 |
Ascorbic acid Ascorbic acid 100 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 2 ml № 10, № 100 | A11GA01 |
Ascorbic acid Ascorbic acid 25 mg №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg №50 | A11GA01 |
Ascorbic acid Ascorbic acid 25 mg № 100 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg № 100 | A11GA01 |
Bisacodyl Bisacodyl 0,01 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,01 g № 10 | A06AB02 |
Carbacid Pechaevskiy Carbacid Pechaevskiy № 20 Chewable tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A02AX |
Dalmaxin Dalmaxin 0,2 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,2 g № 5, № 10 | A05BA |
Diosmectite Diosmectite 3,0 g №10 Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
3,0 g №10 | A07BC05 |
Ergocalciferol (vitamin D2) Ergocalciferol (vitamin D2) 0,125 %, 10 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,125 %, 10 ml № 1 | A11CC01 |
Glibenclamide Glibenclamide 5 mg № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 mg № 30 | А10ВВ01 |
Heksavit Heksavit № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
Kreazim 10000 Kreazim 10000 № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
Kreazim 20000 Kreazim 20000 № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
Lactulose Lactulose 670 mg/ml 200 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 200 ml | A06AD11 |
Lactulose Lactulose 670 mg/ml 100 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 100 ml | A06AD11 |
Lekplex | 2 ml № 5 | А11DВ |
Leksadyl Leksadyl 10 mg № 10 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
10 mg № 10 | А06АВ02 |
Lektac Lektac 150 mg № 10, № 20, № 30 Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 10, № 20, № 30 | A02BA02 |
Loperamide Loperamide 0,002 g № 10, № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,002 g № 10, № 20 | A07DA03 |
Methovitan Methovitan 20 hard capsules Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 hard capsules | А11АВ |
Methyluracil Methyluracil 0,5 g, № 5 ,№ 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,5 g, № 5 ,№ 10 | A14B |
Nevrolek Nevrolek 2 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml № 5 | A11DB |
No-H-Sha No-H-Sha 0,04 g № 10, № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10, № 30 | A03A D02 |
No-H-Sha No-H-Sha 20 mg/mg, 2 ml in ampoules № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/mg, 2 ml in ampoules № 5 | A03AD02 |
No-H-Sha No-H-Sha 0,04 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10 | A03AD02 |
No-H-Sha forte No-H-Sha forte 0,08 g № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,08 g № 30 | A03AD02 |
Ondansetron Ondansetron 4 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
4 mg № 10 | A04AA01 |
Ondansetron Ondansetron 8 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
8 mg № 10 | A04AA01 |
Ondansetron Ondansetron 2 mg/ml 2 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 2 ml № 5 | A04AA01 |
Ondansetron Ondansetron 2 mg/ml 4 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 4 ml № 5 | A04AA01 |
Pancreatin 8000 Pancreatin 8000 № 20, №50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, №50 | A09AA02 |
Pancreazim Pancreazim № 20, № 50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | A09AA02 |
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
Papaverine Papaverine 20 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/ml, 2 ml № 10 | A03AD01 |
Pyridoxine hydrochloride (vitamin В6) Pyridoxine hydrochloride (vitamin В6) 50 mg/ml, 1 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml № 10 | A11HA02 |
Ranitidine Ranitidine 150 mg № 20 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 20 | A02BA02 |
Ranitidine Ranitidine 150 mg №30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg №30 | A02BA02 |
Renalgan Renalgan 5 ml №5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 ml №5 | A03DA02 |
Renalgan Renalgan № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 10 | A03DA02 |
Renalgan Renalgan 2 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml №10 | A03DA02 |
Renalgan Renalgan №20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№20 | A03DA02 |
Retinol acetate (vitamin A) Retinol acetate (vitamin A) 34,4 mg/ml, 10 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
34,4 mg/ml, 10 ml № 1 | A11CA01 |
Revit Revit № 75, № 100 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 75, № 100 | A11BA |
Solizym forte Solizym forte № 20 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA |
Stomolik Stomolik 125 ml № 1 Solution for oral cavity Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
125 ml № 1 | А01АВ12 |
Thiamine chloride (vitamin В1) Thiamine chloride (vitamin В1) 50 mg/ml, 1 ml in ampoules № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml in ampoules № 10 | A11DA01 |
Undevit Undevit № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |